Patents by Inventor Hermann P. T. Ammon

Hermann P. T. Ammon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of boswellic acids for the prophylaxis and/or treatment of damage to and/or inflammation of the islets of Langerhans
    Patent number: 8975228
    Abstract: Disclosed are methods and compositions related to the use of boswellic acids (such as acetyl-11-keto-?-boswellic acid, 11-keto-?-boswellic acid, ?-boswellic acid, acetyl-?-boswellic acid, 9,11-dehydro-?-boswellic acid, acetyl-9,11-dehydro-?-boswellic acid, ?-boswellic acid, acetyl-?-boswellic acid, 11-dehydro-?-boswellic acid, acetyl-9,11-dehydro-?-boswellic acid, lupeolic acid, acetyl lupeolic acid, 12-ursene-2-diketone, incensole, incensole acetate, a derivative, in particular an ester thereof, a pharmaceutically acceptable salt thereof, a combination thereof, or a preparation containing one or more of these compounds) for the human medical or veterinary prophylaxis and/or treatment of: a) damage to and/or inflammation of the islets of Langerhans and/or b) damage to the B-cells of the islets of Langerhans.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: March 10, 2015
    Assignee: Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung E.V.
    Inventor: Hermann P. T. Ammon
  • USE OF BOSWELLIC ACIDS FOR THE PROPHYLAXIS AND/OR TREATMENT OF DAMAGE TO AND/OR INFLAMMATION OF THE ISLETS OF LANGERHANS
    Publication number: 20120070497
    Abstract: Disclosed are methods and compositions related to the use of boswellic acids (such as acetyl-11-keto-?-boswellic acid, 11-keto-?-boswellic acid, ?-boswellic acid, acetyl-?-boswellic acid, 9,11-dehydro-?-boswellic acid, acetyl-9,11-dehydro-?-boswellic acid, ?-boswellic acid, acetyl-?-boswellic acid, 11-dehydro-?-boswellic acid, acetyl-9,11-dehydro-?-boswellic acid, lupeolic acid, acetyl lupeolic acid, 12-ursene-2-diketone, incensole, incensole acetate, a derivative, in particular an ester thereof, a pharmaceutically acceptable salt thereof, a combination thereof, or a preparation containing one or more of these compounds) for the human medical or veterinary prophylaxis and/or treatment of: a) damage to and/or inflammation of the islets of Langerhans and/or b) damage to the B-cells of the islets of Langerhans.
    Type: Application
    Filed: September 22, 2011
    Publication date: March 22, 2012
    Applicant: Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V.
    Inventor: Hermann P.T. Ammon
  • USE OF BOSWELLIC ACID AND ITS DERIVATIVES FOR INHIBITING NORMAL AND INCREASED LEUCOCYTIC ELASTASE OR PLASMIN ACTIVITY
    Publication number: 20100166670
    Abstract: The invention concerns the use of pure boswellic acid, a physiologically acceptable salt, a derivative, a salt of the derivative or a plant preparation containing boswellic acid for preventing and/or combatting diseases which are caused by increased leucocytic elastase or plasmin activity or can be treated by the inhibition of, normal leucocytic elastase or plasmin activity, in human or veterinary medicine. The invention further concerns the use of pure boswellic acid or a physiologically acceptable salt, a derivative, a salt of the derivative or a plant preparation containing boswellic acid for preparing a medicament for treating diseases which are caused by increased leucocytic elastase or plasmin activity or can be treated by the inhibition of normal leucocytic elastase or plasmin activity, in human or veterinary medicine.
    Type: Application
    Filed: December 1, 2009
    Publication date: July 1, 2010
    Applicant: Hermann P. T. Ammon
    Inventors: Hermann P.T. Ammon, Hasan Safayhi
  • USE OF BOSWELLIC ACID AND ITS DERIVATIVES FOR INHIBITING NORMAL AND INCREASED LEUCOCYTIC ELASTASE OR PLASMIN ACTIVITY
    Publication number: 20020010168
    Abstract: The invention concerns the use of pure boswellic acid, a physiologically acceptable salt, a derivative, a salt of the derivative or a plant preparation containing boswellic acid for preventing and/or combatting diseases which are caused by increased leucocytic elastase or plasmin activity or can be treated by the inhibition of normal leucocytic elastase or plasmin activity, in human or veterinary medicine.
    Type: Application
    Filed: June 15, 1998
    Publication date: January 24, 2002
    Inventors: HERMANN P.T. AMMON, HASAN SAFAYHI
  • Use of boswellic acid for treating brain tumors
    Patent number: 6174876
    Abstract: The present invention relates to the use of pure boswellic acid, a physiologically acceptable salt, a derivative, a salt of said derivative or a vegetable preparation containing boswellic acid for the preparation of a pharmaceutical composition for the treatment of brain tumours.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: January 16, 2001
    Assignee: Thomas Simmet
    Inventors: Thomas Simmet, Hermann P. T. Ammon
  • Use of boswellic acid for treating brain tumors
    Patent number: 5919821
    Abstract: The present invention relates to the use of pure boswellic acid, a physiologically acceptable salt, a derivative, a salt of said derivative or a vegetable preparation containing boswellic acid for the preparation of a pharmaceutical composition for the treatment of brain tumours.
    Type: Grant
    Filed: June 10, 1997
    Date of Patent: July 6, 1999
    Assignee: Thomas Simmet
    Inventors: Thomas Simmet, Hermann P. T. Ammon
  • Utilization of cysteine derivatives or salts thereof to enhance insulin secretion of the islets of langerhans of the pancreas
    Patent number: 4829087
    Abstract: Utilization of cysteine derivatives or the salts thereof having the formula: ##STR1## wherein R.sub.1 is a hydrogen atom or an acetyl radical, R.sub.2 is a hydrogen atom, a methyl radical or an ethyl radical, R.sub.3 is a hydrogen atom or a methyl radical, R.sub.4 is a hydrogen atom or a methyl radical and X is a Proton acid, to enhance the glucose-induced insulin secretion of the Islets of Langerhans of the pancreas.
    Type: Grant
    Filed: July 26, 1985
    Date of Patent: May 9, 1989
    Inventor: Hermann P. T. Ammon